(EMAILWIRE.COM, January 18, 2018 ) North America transcatheter aortic valve replacement (TAVR) market is expected to reach USD 1.34 billion by 2021 from USD 0.62 billion in 2016, growing at a CAGR of 16.80% during the forecast period 2016-2021. Transcatheter aortic valve replacement (TAVR) is described as minimally invasive procedure replaces the improper functioning aortic valves. TAVR offers an efficient valve replacement procedure as compared to open-heart surgery for the benefit of high risk patients. Transcatheter heart valve replacement systems are referred as cardiovascular devices replace the old and damaged valves. TAVR is used for the treatment of aortic valve disorders such as severe aortic stenosis, degeneration, & regurgitation. Transcatheter aortic valve replacement devices are integrated with valve frame (made of nitinol or stainless steel), valve leaflets material (made of bovine or cow heart tissue). These aortic valves are available with varied sizes (such as 14mm, 16mm, 18mm, 20mm, 22mm, & 29mm). TAVR is performed during different surgery methods such as transfemoral implantation (through the femoral artery), transapical implantation (through the apex of the heart), transaortic implantation (through the top of right chest), and transcaval implantation (through the femoral vein).

Increasing number patient population adopting for transcatheter heart valve therapy in the U.S., availability of reimbursement systems for TAVR procedures, growing number of clinical trials for new products by manufacturers, and rising demand for transcatheter heart valve surgery in Canada are driving the growth of transcatheter aortic valve replacement (TAVR) market in North America. However, high cost of the transcatheter aortic valves and certain risks associated with TAVR therapy are expected to restrain the growth of transcatheter aortic valve replacement (TAVR) market in North America.

Get a comprehensive overview of the North America transcatheter aortic valve replacement Market: http://www.marketdataforecast.com/market-reports/north-america-transcatheter-aortic-valve-replacement-market-358/



North America transcatheter aortic valve replacement (TAVR) market is segmented based on surgery method, valve frame material, valve size, valve leaflets material, and end users. Based on surgery method, the market is sub-segmented as transfemoral implantation, transapical implantation, transaortic implantation, and transcaval implantation. Of these, transfemoral is estimated to command the largest share of North America transcatheter aortic valve replacement (TAVR) market by surgery method in 2016 and expected to grow at the highest CAGR during the forecast period. Based on valve frame material, the market is segmented as nitinol, stainless steel, and cobalt-chromium. Of these, nitinol segment is expected to account for the largest share of North America transcatheter aortic valve replacement (TAVR) market by valve frame material in 2016.

Market Segmentation:

1 Diagnostic Type

1.1 Computed Tomography

1.2 Magnetic Resonance Imaging

1.3 Ultrasound

1.4 Cerebral angiography

1.5 Nuclear Imaging

2 Surgery Type

2.1 Carotid Endarterectomy

2.2 Angioplasty

2.3 Endovascular Mechanical Thrombectomy



Get accurate market forecast and analysis on the North America transcatheter aortic valve replacement Market Request a sample to stay up-to-date on the main trends affecting this market:
<||>rnhttp://www.marketdataforecast.com/market-reports/north-america-transcatheter-aortic-valve-replacement-market-358/request-sample



Transcatheter valve size market is segmented as 14mm to 18mm, 18mm to 22mm, and 22mm to 29mm. Based on valve leaflets material, the market is segmented as bovine heart tissue, cow heart tissue, and other valve leaflets material. Based on end users, the market is sub-segmented as hospitals, ambulatory surgical centres, & cardiac catheterization laboratories. Of these, hospital segment held the largest share of North America transcatheter aortic valve replacement (TAVR) market by end users in 2016.

On the basis of geographical areas, North America transcatheter aortic valve replacement (TAVR) market is segmented as U.S., and Canada. U.S., accounted for larger share of the North America transcatheter aortic valve replacement (TAVR) market in 2016, whereas Canada is estimated to grow at a higher CAGR during the forecast period 2016-2021.

Scope of the report:

· Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

· Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail

· Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics

· Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis

· Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development

· A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment

· Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies

· An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions

· Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market



Inquire Before buying @ http://www.marketdataforecast.com/market-reports/north-america-transcatheter-aortic-valve-replacement-market-358/inquire



The key players in transcatheter aortic valve replacement (TAVR) market such as, Edwards Lifesciences Corporation (U.S.), Medtronic, Inc. (Ireland), Boston Scientific Corporation (U.S.), Abbott Laboratories (U.S.), St. Jude Medical Inc. (U.S.), JenaValve Technology, Inc. (Germany), Symetis SA (Switzerland), Direct Flow Medical, Inc. (U.S.), Sorin Group (Italy), Meril Life Sciences India Pvt Ltd (India), and Braile Biomedica (Brazil).



About Market Data Forecast
Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages

More about Market Data Forecast

Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results